BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10917561)

  • 1. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.
    Green J; Banks E; Berrington A; Darby S; Deo H; Newton R
    Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
    Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Invest; 2007 Aug; 25(5):340-6. PubMed ID: 17661210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
    Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
    Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
    Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
    Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.